Poseida Therapeutics, Inc.

We are a clinical-stage biopharmaceutical company leveraging our proprietary non-viral gene engineering technologies to create potentially ground-breaking, life-saving allogeneic cell therapies and genetic medicines. Our goal is to deliver better and safer treatments to patients with serious diseases — blood cancers like multiple myeloma, solid tumor cancers like breast and ovarian cancer, and rare genetic diseases impacting adults and children. Our organization is comprised of passionate, innovative, and nimble, results-oriented people driven by science to develop better options for patients with cancer and genetic diseases.